CTCarlton Anthony Taft

Carlton Anthony Taft

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carlton Anthony Taft has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Green Tea Catechins as Potential Drug Scaffolding Molecules in Structural Studies with Diverse Protein Targets

    by Hortensia Gomes Leal, Jinbo Ge, Dongjun Yoo, Michelle Arya, Carlton Anthony Taft, Gemma Rose Topaz, Kimberly Ann Stieglitz

    Previous studies provide substantial evidence that catechins, polyphenol bioactive compounds, exhibit medicinal benefits. These polyphenols are found in abundance in green teas, including a combination of the four major types of catechins: (-)-Epicatechin (EC), (-)-Epicatechin-3-gallate (ECG), (-)- Epigallocatechin (EGC), and (-)- Epigallocatechin-3-gallate (EGCG). Although all four exhibit medicinal benefits, the catechin cited in the literature the most is EGCG, so derivatives of this catechin were selected for these studies. Literature searches identified catechins as biologically active compounds for a diverse set of diseases ranging from cancer, metabolism, neurological, and neuromuscular ailments. A diverse set of potential protein targets for docking with catechin derivatives was first identified as a list (n = 48). The targets were then selected based on the presence of 3D protein coordinates for these targets provided by the Rutgers Consortium for Structural Biology (RCSB) Protein Data Bank (PDB) (n = 10). The surfaces of the 3D protein targets were evaluated with computational methods to identify potential binding sites for the EGCG catechin derivatives. Static and flexible docking was done using target protein binding sites performed with the catechin derivatives followed by molecular dynamics (MD). MD protocols were run to confirm binding in the physiological range and environment. In summary, the results of computational protocols confirmed predicted binding by docking with MD of several catechin derivatives to be used as scaffolds once validated in lab-based assays. Possible changes to these scaffolding molecules that could result in tighter, more specific binding is discussed.


  • Antiparkinsonian Potential of Natural Products: Molecular Docking, Prediction of Pharmacokinetic and Toxicological Properties

    by Henrique B. Lima, Jaderson V. Ferreira, Mariela L. Nery, Gisele A. Chaves, Anderson L. P. da Costa, Lucilene R. de Souza, Bianca L. Marino, Maiara F.B. Brito, Hueldem R.C. Teixeira, Carlos H.T.P. Silva, et al.

    Background: Parkinson's disease (PD) is a neurodegenerative pathology common in the elderly, and it may be related to several factors, such as excessive and continuous use of drugs, alcoholism, cerebral ischemia, among others. Emphasizing that there is still no cure for PD, current pharmacological treatment aims to restore reduced dopaminergic activity in the central nervous system and manage symptoms. However, due to the different side effects caused by antiparkinsonian drugs, their use is recommended just when symptoms are considerably impairing professional performance or the patient's daily tasks. Therefore, studies for the development of new drugs have been conducted, and natural products are gaining importance due to the possibility of discovering new bioactive molecular. In this sense, this research aimed to perform the in silico study of molecules of natural origin for the treatment of PD. Methods: A search for molecules from medicinal plants was carried out, they underwent a pharmacokinetic and toxicological prediction with subsequent molecular docking study, being coupled with the MAO-B enzyme and the dopamine receptor 2. Results: The ginsenosides compounds present an unfavorable pharmacokinetic pattern, which can be explained by their molecular mass, while the other molecules present average patterns, with the exception of kavains, which obtained very satisfactory results. When it comes to toxicity, the molecules curcumin, dihydrokavain, vitexin, kavain and tetrahydrocurcumin did not exhibit any toxic alert. As for the molecular docking study, the compound curcumin stood out with a considerable number of interactions at many amino acid residues relevant to antiparkinsonian activity, both in the MAO-B enzyme and in the D2 receptor. Conclusion: Of 25 molecules of natural products, 3 are good candidates for studies of oral drugs, owing to their excellent pharmacokinetic profile and low probability of being toxic. The curcumin molecule has a great notoriety, as it obtained relevant interactions with the two proteins studied in molecular docking, speciallyin the MAO-B enzyme.

  • Emerging Metal-Halide Perovskite Materials for Enhanced Solar Cells and Light-Emitting Applications

    by Felipe Moreira Pinto, Mary Carmen Mate Durek de Conti, Swayandipta Dey, Esteban Velilla, Carlton A. Taft, Felipe de Almeida La Porta


  • Open Access

    Influence of structural disorder on the photocatalytic properties of ZnS nanocrystals prepared by the one-pot solvothermal approach

    by Victoria Gabriela Benatto, Guilherme da Silva Lopes Fabris, Julio Ricardo Sambrano, Carlton Anthony Taft, Felipe de Almeida La Porta

    This study focuses on the impact of the sulfur vacancies on the photocatalytic response of the ZnS nanocrystals synthesized by solvothermal method varying the concentration of zinc acetate/thiourea precursors. XRD patterns show that these samples have a hexagonal structure with different degrees of crystallinity, varying the crystallite size from 2.48 to 2.85 nm. The UV-Vis data reveals an absorption peak (at about 320 nm) characteristic of ZnS nanocrystals. As a result, a decrease in the bandgap value of these materials was observed from 3.78 to 3.62 eV. In principle, a comparison of these results and theoretical calculations reveals the formation of intermediate levels inside the bandgap due to structural polarization. These findings also corroborate the zeta potential measured for these samples, evidenced by an increase of positive charge of ZnS surfaces. Also, the low Miller-index surfaces, such as (100), (110) and (0001), were investigated by periodic density functional theory calculations, in nice agreement with the experimental data. A photocatalysis mechanism was investigated and confirmed the formation of reactive oxygen species.


  • Development of Monoamine Oxidase B Inhibitors with Antiparkinson Activity

    by Lucilene R. de Souza, Rafael de Matos Picanço, Abraão A. Pinheiro, Karina R. da Silva, Carlton A. Taft, Carlos H. T. de Paula da Silva, Cleydson B. R. dos Santos, Lorane I. da Silva Hage-Melim

    Parkinson's disease (PD) is a debilitating disease that affects the elderly. With the availability of treatment it has become possible to maintain good functional mobility for years, increasing life expectancy of the treated patients. Levodopa is the main form of pharmacological treatment, and is administered along with dopamine agonists monoamine oxidase B inhibitors (MAO-B). However, the use of these agonists causes various side effects. MAO-B is an enzyme that catalyzes the oxidative deamination of neurotransmitters such as dopamine, serotonin, norepinephrine, and epinephrine. This enzyme is thus an important therapeutic target for the treatment of PD. Consequently, in this study we computationally designed new inhibitors of MAO-B compounds as future drug candidates for the treatment of PD. We present three proposals where the changes were made from the compound that had the best results in activity/docking among the inhibitors found in the BindingDB. The compounds were then assessed for their physicochemical properties, biological activity and synthetic accessibility. The results suggest that the three proposals could be promising inhibitors of MAO-B.


  • Ligand and Structure-Based Drug Design as Strategies for the Screening of New BACE1 Inhibitor Candidates

    by Leonardo B. Federico, Jonathan R. de Almeida, Carlton A. Taft, Carlos H. T. de Paula da Silva

    The neurogeneration observed in Alzheimer's disease (AD) is due to the formation of two abnormal structures in the brain of patients with this disease, i.e. neurofibrillary tangles and amyloid plaques. The amyloid plaques are formed by fragments of insoluble beta-amyloid peptides generated by cleaving the amyloid precursor protein (APP) by the beta-secretase enzyme (BACE 1). To date there are no marketed drugs that can stop or slow the progress of AD making it necessary for drug design research in this area, to be undertaken, BACE1 have presented as a major target for delaying the symptoms of AD, since it would prevent inhibition of the formation of insoluble fragments of beta-amyloid protein, and therefore the formation of amyloid plaques. The present study is aimed at screening millions of chemical compounds with pharmaceutical characteristics present in commercial databases, using virtual screening techniques to identify compounds that would inhibit BACE1. Two strategies have been proposed for this: (i) similarity virtual screening followed by docking and (ii) a pharmacophore approach followed by similarity virtual screening. After filtering the compounds, pharmacokinetic and toxicity properties were predicted. Finally two compounds one from each strategy was selected, which could eventually lead to in vitro studies of biological activity.


  • Molecular Dynamics, Density Functional Theory, Pharmacophore Modeling, Molecular Interaction Fields and ADME/Tox Investigation of Novel Bioactive Compounds Interacting with CDK2 Surfaces

    by Fernanda P. Ferreira, Wagner F. Couto, Vanessa Fontana, Carlton A. Taft, Carlos Silva

    We have used docking, virtual screening, pharmacophore modeling, molecular interaction fields, molecular dynamics and pharmacokinetic-toxicity analyses in order to propose novel potential CDK2 inhibitors for cancer treatment. We also have proposed molecular modifications of known inhibitors and evaluated them with respect to pharmacodynamic and pharmacokinetic-toxicity properties. Four proposals have been selected and they indicate new and improved polar and hydrophobic interactions with the enzyme, as well as good pharmacotherapeutic profiles.


  • Open Access

    Theoretical Studies of Doped Solid Oxides for Fuel Cell Applications

    by J. G. Solano Canchaya, A. Rebaza, D. S. Lemelle, C. A. Taft

    Zirconia (ZrO2) is of great importance as a support for systems where high ionic conductivity and mechanical stability are required. Doping/defects have a significant effect on the physical properties of this oxide by stabilizing the most symmetric phases, increasing the ionic conductivity and possible facilitating three phase interconnections in solid oxide fuel cells (SOFCs). Although Zirconia in its pure form exhibits different structures at high temperatures when it is alloyed with other oxides the high temperature cubic polymorph can be stabilized to temperatures low enough for fuel cell applications. Although there has been tremendous technological investment to obtain better materials, we are still far from an optimum solution. We start in this work with theoretical calculations as a support/participation in the search for more appropriate materials that will make this important technology viable in a wide range of applications in the near future. The calculations were performed in the framework of Density Functional (DFT) pseudopotential theory using the Projector Augmented Wave (PAW) with various approximations to the exchange-correlation functional. We investigate structural, electronic/band structure, density of states and charge densities for pure zirconia taking into consideration as well different dopants, their concentrations as well as vacancies for the various polymorphs with interest in fuel cell electrolyte applications.


  • Phospholipase A2 Inhibitors Isolated From Medicinal Plants: Alternative Treatment Against Snakebites

    by Lorane I.S. Hage-Melim, Suely V. Sampaio, Carlton A. Taft, Carlos H.T.P. Silva

    Many plants are used in traditional medicine as active agents against various effects of snake bites. Phospholipase A2 enzymes are commonly found in venoms of snakes of the Viperidae and Elaphidae families, which are their main components. This article presents an overview of inhibitors isolated from plants, which show antiophidian properties.


  • Virtual Screening, Molecular Interaction Field, Molecular Dynamics, Docking, Density Functional, and ADMET Properties of Novel AChE Inhibitors in Alzheimer's Disease

    by Carlos H. T. P. da Silva, Ivone Carvalho, C. A. Taft

    Alzheimer's disease (AD) affects approximately 10% of the world's population with 65 years of age, being the most common form of dementia in adults and is characterized by senile plaquets and cholinergic deficits. Many drugs currently used for the treatment of the AD are based on the improvement of cholinergic neurotransmission achieved by Acetylcho- linesterase (AChE) inhibition, the enzyme responsible for acetylcholine hydrolysis. We have focused in this work on the usage of computer-aided molecular design by virtual screening, molecular dynamics with implicit and explicit water solvation, density functional, molecular interaction field studies, docking procedures, ADMET predictions in order to propose novel potential AChE inhibitor for the treatment of Alzheimer's disease.